Clinical outcomes of systemic therapy for metastatic renal cell carcinoma patients on hemodialysis

被引:0
|
作者
Iwasa, Shun [1 ]
Mizuno, Ryuichi [1 ]
Yasumizu, Yota [1 ]
Tanaka, Nobuyuki [1 ]
Takeda, Toshikazu [1 ]
Matsumoto, Kazuhiro [1 ]
Morita, Shinya [1 ]
Kosaka, Takeo [1 ]
Asanuma, Hiroshi [1 ]
Oya, Mototsugu [1 ]
机构
[1] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan
关键词
D O I
10.1016/j.annonc.2023.09.219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MO25-2
引用
收藏
页码:S1412 / S1412
页数:1
相关论文
共 50 条
  • [41] Impact of precise quantitative assessment of visceral obesity on outcomes of patients with metastatic renal cell carcinoma treated with systemic therapy.
    Mizuno, Ryuichi
    Miyajima, Akira
    Hayakawa, Nozomi
    Kikuchi, Eiji
    Mikami, Shuji
    Jinzaki, Masahiro
    Oya, Mototsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [42] Outcome of active surveillance prior to systemic target therapy in patients with metastatic renal cell carcinoma
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Itoh, Kuniaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [43] Systemic therapy in patients with metastatic Xp11.2 translocation renal cell carcinoma.
    Yan, Xieqiao
    Li, Siming
    Chi, Zhihong
    Si, Lu
    Cui, Chuanliang
    Kong, Yan
    Zhou, Li
    Tang, Bixia
    Wu, Xiaowen
    Mao, Lili
    Wang, Xuan
    Lian, Bin
    Bai, Xue
    Dai, Jie
    Guo, Jun
    Sheng, Xinan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [44] Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma
    YueJun Du
    Sascha Pahernik
    Boris Hadaschik
    Dogu Teber
    Stephan Duensing
    Dirk Jäger
    Markus Hohenfellner
    Carsten Grüllich
    Journal of Neuro-Oncology, 2016, 130 : 221 - 228
  • [45] Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma
    Du, YueJun
    Pahernik, Sascha
    Hadaschik, Boris
    Teber, Dogu
    Duensing, Stephan
    Jaeger, Dirk
    Hohenfellner, Markus
    Gruellich, Carsten
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (01) : 221 - 228
  • [46] An observational study of metastatic renal cell carcinoma patients prior to initiation of initial systemic therapy
    Plimack, Elizabeth R.
    Nemec, Cheryl
    Elson, Paul
    Suarez, Cristina
    Dorff, Tanya B.
    Larkin, James M. G.
    McAleer, Cecilia
    Nunez, Isaac
    Fisher, Rosalie Anne
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases
    Semenescu, Liliana Eleonora
    Kamel, Amira
    Ciubotaru, Vasile
    Baez-Rodriguez, Silvia Mara
    Furtos, Mircea
    Costachi, Alexandra
    Dricu, Anica
    Tataranu, Ligia Gabriela
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (09) : 7680 - 7704
  • [48] Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma
    Bergerot, Paulo Gustavo
    Bergerot, Cristiane Decat
    Philip, Errol J.
    Meza, Luis
    Dizman, Nazli
    Hsu, JoAnn
    Pal, Sumanta Kumar
    KIDNEY CANCER, 2019, 3 (01) : 63 - 70
  • [49] CLINICAL OUTCOMES OF AXITINIB VERSUS SUNITINIB AS A FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA IN JAPANESE PATIENTS
    Kiso, Yusuke
    Inoue, Takamitsu
    Nara, Taketoshi
    Kanda, Sohei
    Numakura, Kazuyuki
    Tsuruta, Hiroshi
    Saito, Mitsuru
    Narita, Shintaro
    Satoh, Shigeru
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2018, 199 (04): : E874 - E874
  • [50] Clinical Results and Pharmacokinetics of Sorafenib in Chronic Hemodialysis Patients with Metastatic Renal Cell Carcinoma in a Single Center
    Kennoki, Takafumi
    Kondo, Tsunenori
    Kimata, Naoki
    Murakami, Jun
    Ishimori, Isamu
    Nakazawa, Hayakazu
    Hashimoto, Yasunobu
    Kobayashi, Hirohito
    Iizuka, Junpei
    Takagi, Toshio
    Yoshida, Kazuhiko
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) : 647 - 655